Home / Rivaroxaban / Ireland
IE ATC B01AF01 · updated 2 Nov 2026
Rivaroxaban shortage in Ireland
Is there a Rivaroxaban shortage in Ireland?
Yes. As of 2 Nov 2026, 3 Rivaroxaban products are reported short in Ireland, the first since 10 Aug 2026. The company estimate for the return is 16 Dec 2026 (latest 19 Dec 2026). Main reason: manufacturing problem.
Also short in United States, Canada, Germany, France, Italy, Spain, Austria, Belgium, Switzerland, Czechia, Sweden, Japan. All countries.
Affected products in Ireland
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IE | Xarelto 1 mg / ml granules for oral suspension 100ml (51.7mg) | Bayer AG | 10 Aug 2026 | 19 Dec 2026 | Increased demand Unexpected increased demand |
| IE | Rivaroxaban Accord 2.5 mg film-coated tablets 56 | Accord Healthcare S.L.U. | 15 Oct 2026 | not given | Manufacturing problem Manufacturing delay |
| IE | Rivaroxaban Accord 15 mg film-coated tablets | Accord Healthcare S.L.U. | 16 Oct 2026 | 16 Dec 2026 | Manufacturing problem Manufacturing delay |
Source
HPRA (Health Products Regulatory Authority). Official list. Shortages notified to the HPRA by marketing-authorisation holders; one row per pack.